Тёмный

Using REVLIMID as a Successful Treatment for Myeloma Patients with Kidney Involvement 

HealthTree Foundation for Multiple Myeloma
Подписаться 6 тыс.
Просмотров 2,5 тыс.
50% 1

Recorded on September 14th, 2022 as part of the Myeloma Kidney Involvement Chapter in the Myeloma Crowd Community by HealthTree Program with Marc Braunstein, MD, PhD.
The HealthTree Foundation for Multiple Myeloma brings information from the experts to the patients! Learn more at www.healthtree.org/myeloma/co...
HealthTree Cure Hub helps you find your best treatment options and accelerate a cure for multiple myeloma. Join today at www.healthtree.org/
Follow HealthTree:
healthtreeformm
healthtreeformultiplemyeloma
instragram.com/healthtreeformultiplemyeloma

Наука

Опубликовано:

 

18 сен 2022

Поделиться:

Ссылка:

Скачать:

Готовим ссылку...

Добавить в:

Мой плейлист
Посмотреть позже
Комментарии : 3   
@thomasfraser9072
@thomasfraser9072 Год назад
Why is Dex essentially given with all the treatments for Multiple Myeloma? Is it to lower the informatory response from treatment? Even then is it really needed when Vitamin D3 10,000IU and Pepcid an H2 blocker could do the same?
@HealthTreeForMyeloma
@HealthTreeForMyeloma Год назад
Thomas, this is a great question and one that we hope to address in upcoming events. As a short answer, clinical trials have proven in to improve efficacy and synergy of other myeloma medications. There are also several clinical trials testing effective dexamethasone dosages, replacements, and removing dex all together. Stay tuned!
@vnvela8613
@vnvela8613 Месяц назад
Whoa?
Далее
CCF Webinar: Precision Medicine in Cholangiocarcinoma
1:06:37
Understanding Your Myeloma Labs
55:38
Просмотров 2,8 тыс.
Will the Smoldering Myeloma Diagnosis Phase Out?
59:54
Просмотров 3,3 тыс.
ЗАБЫТЫЙ IPHONE 😳
0:31
Просмотров 14 тыс.